Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.48 - $5.33 $483 - $5,367
-1,007 Reduced 0.42%
237,427 $149,000
Q3 2022

Nov 14, 2022

BUY
$4.65 - $7.37 $1.11 Million - $1.76 Million
238,434 New
238,434 $1.15 Million
Q2 2022

Aug 15, 2022

SELL
$4.21 - $11.15 $3.63 Million - $9.62 Million
-862,926 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$8.48 - $18.1 $15.2 Million - $32.5 Million
-1,793,708 Reduced 67.52%
862,926 $9.28 Million
Q4 2021

Feb 11, 2022

SELL
$15.37 - $22.5 $7.66 Million - $11.2 Million
-498,521 Reduced 15.8%
2,656,634 $45.5 Million
Q2 2021

Aug 16, 2021

SELL
$15.31 - $24.63 $25.3 Million - $40.7 Million
-1,650,990 Reduced 34.35%
3,155,155 $59.7 Million
Q1 2021

May 17, 2021

BUY
$24.23 - $27.06 $116 Million - $130 Million
4,806,145 New
4,806,145 $117 Million

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.67B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.